欧美亚洲综合一区-成人久久久久久久久-久久久黄色一级片-老师爽好大快深点男男h-国产色男浴室洗澡gay2022-女人张开腿让男人捅app-亚洲一区二区三区爽爽爽爽爽-国产91热爆ts人妖月奴-余罪第一季全24集观看,日韩a电影,婷婷亚洲五月色综合,神马快播

歡迎進(jìn)入上海起發(fā)實(shí)驗(yàn)試劑有限公司!
新聞中心
首頁(yè) > 新聞中心 > 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理

熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理

 更新時(shí)間:2012-11-21 點(diǎn)擊量:2394

 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理!

 

Our Collaborators

NeoClone has focused its business on growing through collaboration.  As we continue to refine our approach to developing fully human antibodies we have partnered with other groups to help validate our system.  Our current collaborators include:

  • University of Wisconsin - Madison, Dr. Manish Patankar, PhD. Dr. Patankar is a noted expert in the area of ovarian cancer and NeoClone is working with him to develop fully human antibodies for the treatment of this devastating disease.
  • University of California - Los Angeles, Dr. Kathie Ferbas, PhD. Dr. Ferbas has an active program for discovering new treatments for AIDS and is working with NeoClone to advance these research goals.
  • InflammatoRx Inc., is an early stage company located in Quebec, Canada. NeoClone is working with InflammatoRx to develop fully human antibodies against their inflammatory biomarker of interest.

NeoClone does have capacity for additional collaboration. Please contact us if this is of interest to you.